Prognostic outcomes in Japanese patients with metastatic castration-sensitive prostate cancer: Comparative assessments between conventional androgen deprivation therapy (ADT) and ADT with novel androgen receptor signal inhibitor.
Hiromitsu WatanabeKeita NakaneKiyoshi TakaharaTaku NaikiTakahiro YasuiRyoichi ShirokiTakuya KoieHideaki MiyakePublished in: International journal of urology : official journal of the Japanese Urological Association (2024)
Combined use of ARSIs with ADT could improve the prognostic outcomes of mCSPC patients, particularly those in the LATITUDE high-risk group, in real-world clinical practice in Japan.